Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL B22GK 4 0 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 1 2 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL B22GK 4 0 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 1 2 IN PLASTIC CONTAINER.
PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER vs PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol B22GK 4/0 is a sterile, bicarbonate-based hemofiltration solution used in continuous renal replacement therapy (CRRT). It replaces electrolytes and buffers in the blood, correcting metabolic acidosis and removing waste products via convection and diffusion. The solution contains bicarbonate as a buffer to maintain acid-base balance.
Prismasol BK 0/0/1.2 is a sterile, nonpyrogenic, bicarbonate-buffered solution used for continuous renal replacement therapy (CRRT). It provides electrolyte composition to maintain acid-base balance and electrolyte homeostasis during hemofiltration or hemodialysis. Its mechanism involves correction of metabolic acidosis via bicarbonate buffer, and removal of uremic toxins through convective and/or diffusive clearance.
Continuous renal replacement therapy (CRRT): 1.5-2.0 L/h effluent rate, typically administered as continuous venovenous hemofiltration (CVVH) or hemodiafiltration (CVVHDF). Route: intravenous via CRRT circuit. Frequency: continuous infusion.
Continuous renal replacement therapy (CRRT): 1.2 mmol/L potassium dialysate/ replacement fluid, infused at a rate of 2000-3000 mL/hour, adjusted to achieve desired electrolyte balance and fluid removal.
None Documented
None Documented
Not applicable as a drug; the half-life of infused bicarbonate/lactate in patients is approximately 5–10 minutes for lactate conversion and bicarbonate distribution, but this is not relevant to the solution itself.
Not applicable as a drug; the half-life of bicarbonate in CRRT depends on the dialysis dose and patient's metabolic rate. Typical half-life of infused bicarbonate is minutes due to rapid equilibration. The electrolytes are continuously removed during therapy.
Prismasol B22GK 4/0 is a dialysis solution containing electrolytes and buffer (bicarbonate/lactate). It is not systemically absorbed; during continuous renal replacement therapy (CRRT), solutes and fluid are removed via hemofiltration/dialysis. The solution components are eliminated by the dialysis membrane and not subject to systemic excretion.
PRISMASOL BK 0/0/1.2 is a bicarbonate-based substitution fluid used in continuous renal replacement therapy (CRRT). It is not absorbed systemically; its components are eliminated according to their individual pharmacokinetics during CRRT. Bicarbonate is primarily eliminated via the dialysate/effluent (renal replacement route). Calcium and magnesium are also removed via CRRT. Less than 1% is excreted in feces or bile.
Category C
Category C
Dialysis Solution
Dialysis Solution